Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Boor

Showing results (41-50 of 357) with videos related to

Pageof 36
Sort By:
Seminars in Immunopathology|April 9, 2021
How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?Roman David Bülow, Daniel Dimitrov, Peter Boor, et al.
Acta Ophthalmologica|August 9, 2020
Postmortem conjunctival and nasopharyngeal swabs in SARS-CoV-2 infected and uninfected patientsMatthias Fuest, Peter Boor, Ruth Knuechel, et al.
Expert Reviews in Molecular Medicine|January 19, 2018
Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseasesPeter Celec, Barbora Vlková, Lucia Lauková, et al.
American Journal of Nephrology|August 30, 2008
Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin systemKatarína Sebeková, Maria Lill, Peter Boor, et al.
American Journal of Nephrology|September 25, 2007
The selective TP receptor antagonist, S18886 (terutroban), attenuates renal damage in the double transgenic rat model of hypertensionKatarína Sebeková, Anika Ramuscak, Peter Boor, et al.
Kidney International|September 21, 2025
Advances in computational nephropathologyDavid L Hölscher, Roman D Bülow, Martin Strauch, et al.
Microbial Biotechnology|January 26, 2021
Loop-mediated isothermal amplification for the detection of SARS-CoV-2 in salivaMonika Janíková, Július Hodosy, Peter Boor, et al.
Seminars in Immunopathology|May 8, 2021
Correction to: How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?Roman David Bülow, Daniel Dimitrov, Peter Boor, et al.
The Lancet Regional Health. Europe|May 9, 2022
First report from the German COVID-19 autopsy registrySaskia von Stillfried, Roman David Bülow, Rainer Röhrig, et al.
Pathologie (Heidelberg, Germany)|April 10, 2024
[Artificial intelligence in kidney transplant pathology]Roman David Bülow, Yu-Chia Lan, Kerstin Amann, et al.
Pageof 36

Showing results (41-50 of 357) with videos related to

Sort By:
Pageof 36
Seminars in Immunopathology|April 9, 2021
How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?Roman David Bülow, Daniel Dimitrov, Peter Boor, et al.
Acta Ophthalmologica|August 9, 2020
Postmortem conjunctival and nasopharyngeal swabs in SARS-CoV-2 infected and uninfected patientsMatthias Fuest, Peter Boor, Ruth Knuechel, et al.
Expert Reviews in Molecular Medicine|January 19, 2018
Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseasesPeter Celec, Barbora Vlková, Lucia Lauková, et al.
American Journal of Nephrology|August 30, 2008
Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin systemKatarína Sebeková, Maria Lill, Peter Boor, et al.
American Journal of Nephrology|September 25, 2007
The selective TP receptor antagonist, S18886 (terutroban), attenuates renal damage in the double transgenic rat model of hypertensionKatarína Sebeková, Anika Ramuscak, Peter Boor, et al.
Kidney International|September 21, 2025
Advances in computational nephropathologyDavid L Hölscher, Roman D Bülow, Martin Strauch, et al.
Microbial Biotechnology|January 26, 2021
Loop-mediated isothermal amplification for the detection of SARS-CoV-2 in salivaMonika Janíková, Július Hodosy, Peter Boor, et al.
Seminars in Immunopathology|May 8, 2021
Correction to: How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?Roman David Bülow, Daniel Dimitrov, Peter Boor, et al.
The Lancet Regional Health. Europe|May 9, 2022
First report from the German COVID-19 autopsy registrySaskia von Stillfried, Roman David Bülow, Rainer Röhrig, et al.
Pathologie (Heidelberg, Germany)|April 10, 2024
[Artificial intelligence in kidney transplant pathology]Roman David Bülow, Yu-Chia Lan, Kerstin Amann, et al.
Pageof 36